Endocrine Therapy Plus Targeted Agents in MBC Endocrine Therapy Plus Targeted Agents in MBC

Endocrine therapy remains the mainstay of treatment in metastatic breast cancer. Dr Erica Mayer discusses adding targeted agents as clinicians strive to improve therapeutic options and efficacy.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Article Source Type: news